{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "23",
                "@timestamp": "2021-02-23T15:32:27.000027-05:00",
                "@year": "2021",
                "@month": "02"
            },
            "ait:date-sort": {
                "@day": "24",
                "@year": "2019",
                "@month": "05"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Janssen/Tibotec"},
                {
                    "xocs:funding-agency-matched-string": "BMS",
                    "xocs:funding-agency-acronym": "BMS",
                    "xocs:funding-agency": "Bristol-Myers Squibb",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100002491",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Merck",
                    "xocs:funding-agency": "Merck",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004334",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Chiang Mai University",
                    "xocs:funding-agency-acronym": "CMU",
                    "xocs:funding-agency": "Chiang Mai University",
                    "xocs:funding-id": "PHD/0114/2558",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002842",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Chulalongkorn University",
                    "xocs:funding-agency-acronym": "CU",
                    "xocs:funding-agency": "Chulalongkorn University",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Thailand Research Fund",
                    "xocs:funding-agency-acronym": "TRF",
                    "xocs:funding-agency": "Thailand Research Fund",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004396",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2021-05-12T07:31:28.566905Z",
            "xocs:funding-text": "K Ruxrungtham has received the Senior Research Scholar Award from the Thailand Research Fund and the Research Professor Fund from Chulalongkorn University, Bangkok, Thailand. K Ruxrungtham also received honoraria or consultation fees from Merck, Roche, Jensen-Cilag, Tibotec, Mylan and GPO (Governmental pharmaceutical organization, Thailand) as well as participated in a company sponsored speaker\u2019s bureau from Abbott, Gilead, Bristol-Myers Squibb, Merck, Roche, Jensen-Cilag, GlaxoSmithKline and GPO (Governmental pharmaceutical organization). DM Burger served on advisory board and participated in a company sponsored speaker\u2019s bureau for Merck, BMS, Janssen/Tibotec, Gilead, ViiV Healthcare and Abbvie. DM Burger has received research grants from Merck, BMS, Janssen/Tibotec and ViiV Healthcare. This study was supported by Chiang Mai University and the Royal Golden Jubilee PhD Program, The Thailand Research Fund (grant number PHD/0114/2558). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60000881",
                            "@country": "tha",
                            "city": "Chiang Mai",
                            "organization": [
                                {"$": "Department of Pharmaceutical Care"},
                                {"$": "Faculty of Pharmacy"},
                                {"$": "Chiang Mai University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60000881",
                                "@dptid": "103084327"
                            },
                            "ce:source-text": "Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand",
                            "@dptid": "103084327"
                        },
                        "author": [
                            {
                                "ce:given-name": "Noppaket",
                                "preferred-name": {
                                    "ce:given-name": "Noppaket",
                                    "ce:initials": "N.",
                                    "ce:surname": "Singkham",
                                    "ce:indexed-name": "Singkham N."
                                },
                                "@seq": "1",
                                "ce:initials": "N.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Singkham",
                                "@auid": "55524284500",
                                "ce:indexed-name": "Singkham N."
                            },
                            {
                                "ce:given-name": "Baralee",
                                "preferred-name": {
                                    "ce:given-name": "Baralee",
                                    "ce:initials": "B.",
                                    "ce:surname": "Punyawudho",
                                    "ce:indexed-name": "Punyawudho B."
                                },
                                "@seq": "10",
                                "ce:initials": "B.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Punyawudho",
                                "@auid": "23976628300",
                                "ce:indexed-name": "Punyawudho B."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60000881",
                            "@country": "tha",
                            "city": "Chiang Mai",
                            "organization": [
                                {"$": "Pharmacy"},
                                {"$": "Faculty of Pharmacy"},
                                {"$": "Chiang Mai University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60000881",
                                "@dptid": "113666685"
                            },
                            "ce:source-text": "PhD's Degree Program in Pharmacy, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand",
                            "@dptid": "113666685"
                        },
                        "author": [{
                            "ce:given-name": "Noppaket",
                            "preferred-name": {
                                "ce:given-name": "Noppaket",
                                "ce:initials": "N.",
                                "ce:surname": "Singkham",
                                "ce:indexed-name": "Singkham N."
                            },
                            "@seq": "1",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Singkham",
                            "@auid": "55524284500",
                            "ce:indexed-name": "Singkham N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60016965",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "HIV-NAT"},
                                {"$": "Thai Red Cross AIDS Research Centre"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60016965"},
                                {"@afid": "60031780"}
                            ],
                            "ce:source-text": "HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand"
                        },
                        "author": [
                            {
                                "ce:given-name": "Anchalee",
                                "preferred-name": {
                                    "ce:given-name": "Anchalee",
                                    "ce:initials": "A.",
                                    "ce:surname": "Avihingsanon",
                                    "ce:indexed-name": "Avihingsanon A."
                                },
                                "@seq": "2",
                                "ce:initials": "A.",
                                "@date-locked": "2019-08-05T13:18:33.382",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Avihingsanon",
                                "@auid": "57196347321",
                                "ce:indexed-name": "Avihingsanon A."
                            },
                            {
                                "ce:given-name": "Narukjaporn",
                                "preferred-name": {
                                    "ce:given-name": "Narukjaporn",
                                    "ce:initials": "N.",
                                    "ce:surname": "Thammajaruk",
                                    "ce:indexed-name": "Thammajaruk N."
                                },
                                "@seq": "3",
                                "ce:initials": "N.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Thammajaruk",
                                "@auid": "36451572800",
                                "ce:indexed-name": "Thammajaruk N."
                            },
                            {
                                "ce:given-name": "Kiat",
                                "preferred-name": {
                                    "ce:given-name": "Kiat",
                                    "ce:initials": "K.",
                                    "ce:surname": "Ruxrungtham",
                                    "ce:indexed-name": "Ruxrungtham K."
                                },
                                "@seq": "4",
                                "ce:initials": "K.",
                                "@date-locked": "2019-07-29T08:42:13.924",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Ruxrungtham",
                                "@auid": "7004208798",
                                "ce:indexed-name": "Ruxrungtham K."
                            },
                            {
                                "ce:given-name": "Torsak",
                                "preferred-name": {
                                    "ce:given-name": "Torsak",
                                    "ce:initials": "T.",
                                    "ce:surname": "Bunupuradah",
                                    "ce:indexed-name": "Bunupuradah T."
                                },
                                "@seq": "5",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Bunupuradah",
                                "@auid": "15836773400",
                                "ce:indexed-name": "Bunupuradah T."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113019942"
                            },
                            "ce:source-text": "Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "113019942"
                        },
                        "author": [
                            {
                                "ce:given-name": "Anchalee",
                                "preferred-name": {
                                    "ce:given-name": "Anchalee",
                                    "ce:initials": "A.",
                                    "ce:surname": "Avihingsanon",
                                    "ce:indexed-name": "Avihingsanon A."
                                },
                                "@seq": "2",
                                "ce:initials": "A.",
                                "@date-locked": "2019-08-05T13:18:33.382",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Avihingsanon",
                                "@auid": "57196347321",
                                "ce:indexed-name": "Avihingsanon A."
                            },
                            {
                                "ce:given-name": "Kiat",
                                "preferred-name": {
                                    "ce:given-name": "Kiat",
                                    "ce:initials": "K.",
                                    "ce:surname": "Ruxrungtham",
                                    "ce:indexed-name": "Ruxrungtham K."
                                },
                                "@seq": "4",
                                "ce:initials": "K.",
                                "@date-locked": "2019-07-29T08:42:13.924",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Ruxrungtham",
                                "@auid": "7004208798",
                                "ce:indexed-name": "Ruxrungtham K."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60199578",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Ramathibodi Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60199578",
                                    "@dptid": "125763061"
                                },
                                {"@afid": "60012718"}
                            ],
                            "ce:source-text": "Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "125763061"
                        },
                        "author": [{
                            "ce:given-name": "Sasisopin",
                            "preferred-name": {
                                "ce:given-name": "Sasisopin",
                                "ce:initials": "S.",
                                "ce:surname": "Kiertiburanakul",
                                "ce:indexed-name": "Kiertiburanakul S."
                            },
                            "@seq": "6",
                            "ce:initials": "S.",
                            "@date-locked": "2019-12-04T04:05:09.902",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Kiertiburanakul",
                            "@auid": "6506539792",
                            "ce:indexed-name": "Kiertiburanakul S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60026046",
                            "@country": "tha",
                            "city": "Khon Kaen",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Khon Kaen University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60026046",
                                    "@dptid": "117186206"
                                },
                                {"@afid": "60017165"}
                            ],
                            "ce:source-text": "Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand",
                            "@dptid": "117186206"
                        },
                        "author": [{
                            "ce:given-name": "Ploenchan",
                            "preferred-name": {
                                "ce:given-name": "Ploenchan",
                                "ce:initials": "P.",
                                "ce:surname": "Chetchotisakd",
                                "ce:indexed-name": "Chetchotisakd P."
                            },
                            "@seq": "7",
                            "ce:initials": "P.",
                            "@date-locked": "2019-09-05T03:23:46.733",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chetchotisakd",
                            "@auid": "56992885200",
                            "ce:indexed-name": "Chetchotisakd P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Netherlands",
                            "@afid": "60002573",
                            "@country": "nld",
                            "city": "Nijmegen",
                            "organization": [
                                {"$": "Department of Pharmacy"},
                                {"$": "Radbound University Medical Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60002573",
                                "@dptid": "112954895"
                            },
                            "ce:source-text": "Department of Pharmacy, Radbound University Medical Center, Nijmegen, The Netherlands",
                            "@dptid": "112954895"
                        },
                        "author": [{
                            "ce:given-name": "David M.",
                            "preferred-name": {
                                "ce:given-name": "David M.",
                                "ce:initials": "D.M.",
                                "ce:surname": "Burger",
                                "ce:indexed-name": "Burger D.M."
                            },
                            "@seq": "8",
                            "ce:initials": "D.M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Burger",
                            "@auid": "55540576000",
                            "ce:indexed-name": "Burger D.M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Australia",
                            "@afid": "60028333",
                            "@date-locked": "2020-12-02T21:59:53.342",
                            "@country": "aus",
                            "city": "Sydney",
                            "organization": [
                                {"$": "Faculty of Medicine"},
                                {"$": "University of New South Wales"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60028333"},
                                {"@afid": "60011463"}
                            ],
                            "ce:source-text": "Faculty of Medicine, University of New South Wales, Sydney, Australia"
                        },
                        "author": [{
                            "ce:given-name": "Sean",
                            "preferred-name": {
                                "ce:given-name": "Sean",
                                "ce:initials": "S.",
                                "ce:surname": "Emery",
                                "ce:indexed-name": "Emery S."
                            },
                            "@seq": "9",
                            "ce:initials": "S.",
                            "@date-locked": "2019-12-13T06:53:58.909",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Emery",
                            "@auid": "57188785246",
                            "ce:indexed-name": "Emery S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60000881",
                            "@country": "tha",
                            "city": "Chiang Mai",
                            "organization": [
                                {"$": "Pharmacoepidemiology and Statistics Research Center (PESRC)"},
                                {"$": "Faculty of Pharmacy"},
                                {"$": "Chiang Mai University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60000881",
                                "@dptid": "120188922"
                            },
                            "ce:source-text": "Pharmacoepidemiology & Statistics Research Center (PESRC), Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand",
                            "@dptid": "120188922"
                        },
                        "author": [{
                            "ce:given-name": "Baralee",
                            "preferred-name": {
                                "ce:given-name": "Baralee",
                                "ce:initials": "B.",
                                "ce:surname": "Punyawudho",
                                "ce:indexed-name": "Punyawudho B."
                            },
                            "@seq": "10",
                            "ce:initials": "B.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Punyawudho",
                            "@auid": "23976628300",
                            "ce:indexed-name": "Punyawudho B."
                        }]
                    }
                ],
                "citation-title": "Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients",
                "abstracts": "© 2019 Future Medicine Ltd.Aim: To evaluate the influence of genetic polymorphisms on plasma trough concentrations of atazanavir (ATV) and ritonavir (RTV). Patients & methods: The concentration-to-dose ratios were compared between different genotype groups of CYP3A5, ABCB1, SLCO1B1 and NR1I2 in 490 patients. Multiple regression analysis was used to examine the association between genetic and clinical factors and log-transformed concentration-to-dose ratio of ATV and RTV. Results: Higher concentrations of ATV and RTV were significantly associated with CYP3A5 6986 GG and SLCO1B1 521 TC or CC. Female patients had significantly higher ATV plasma concentration than male patients. Conclusion: Genetic polymorphisms and gender are factors affecting the variability of ATV and RTV concentrations in the Thai population. Thus, genetic testing is worth considering when atazanavir + low dose ritonavir is prescribed.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "@country": "tha",
                        "city": "Chiang Mai",
                        "organization": [
                            {"$": "Department of Pharmaceutical Care"},
                            {"$": "Faculty of Pharmacy"},
                            {"$": "Chiang Mai University"}
                        ],
                        "ce:source-text": "Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Baralee",
                        "ce:initials": "B.",
                        "ce:surname": "Punyawudho",
                        "ce:indexed-name": "Punyawudho B."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "atazanavir",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "CYP3A5 6986A>G",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "plasma concentrations",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "polymorphisms",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "ritonavir",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "SLCO1B1 521T>C",
                            "@xml:lang": "eng"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://www.futuremedicine.com/loi/pgs?cookieSet=1",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Pharmacogenomics",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "20",
                            "@issue": "7"
                        },
                        "pagerange": {
                            "@first": "517",
                            "@last": "527"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Pharmacogenomics",
                    "publicationdate": {
                        "month": "05",
                        "year": "2019",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "24 May 2019"
                        },
                        "day": "24"
                    },
                    "codencode": "PARMF",
                    "sourcetitle-abbrev": "Pharmacogenomics",
                    "@country": "gbr",
                    "issn": [
                        {
                            "$": "17448042",
                            "@type": "electronic"
                        },
                        {
                            "$": "14622416",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2019"},
                    "publisher": {
                        "publishername": "Future Medicine Ltd.",
                        "ce:e-address": {
                            "$": "info@futuremedicine.com",
                            "@type": "email"
                        }
                    },
                    "@srcid": "21167"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "22",
                                    "classification-description": "Human Genetics"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "4",
                                    "classification-description": "Microbiology: Bacteriology, Mycology, Parasitology and Virology"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "1313"},
                                {"$": "1311"},
                                {"$": "3004"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "BIOC"},
                                {"$": "PHAR"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "198904-31-3",
                                    "chemical-name": "atazanavir"
                                },
                                {
                                    "cas-registry-number": "336874-97-6",
                                    "chemical-name": "cytochrome P450 3A5"
                                },
                                {
                                    "cas-registry-number": "259206-22-9",
                                    "chemical-name": "pregnane X receptor"
                                },
                                {
                                    "cas-registry-number": "155213-67-5",
                                    "chemical-name": "ritonavir"
                                },
                                {
                                    "cas-registry-number": "329322-82-9",
                                    "chemical-name": "cytochrome P450 3A"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Anti-HIV Agents"},
                                {"chemical-name": "Atazanavir Sulfate"},
                                {"chemical-name": "CYP3A5 protein, human"},
                                {"chemical-name": "Cytochrome P-450 CYP3A"},
                                {"chemical-name": "HIV Protease Inhibitors"},
                                {"chemical-name": "Liver-Specific Organic Anion Transporter 1"},
                                {"chemical-name": "Ritonavir"},
                                {"chemical-name": "SLCO1B1 protein, human"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This study was supported by Chiang Mai University and the Royal Golden Jubilee PhD Program, The Thailand Research Fund (grant number PHD/0114/2558). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.",
                        "@xml:lang": "eng"
                    },
                    "grant": {
                        "grant-id": "PHD/0114/2558",
                        "grant-acronym": "TRF",
                        "grant-agency": {
                            "@iso-code": "tha",
                            "$": "Thailand Research Fund"
                        },
                        "grant-agency-id": "501100004396"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2019 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "In-Data-Review",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "EMBIO"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "12",
                    "@timestamp": "BST 14:57:03",
                    "@year": "2019",
                    "@month": "06"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "627847894",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "917689243",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20190362939",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "2018153030",
                            "@idtype": "EMBIO"
                        },
                        {
                            "$": "31124411",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20190997424",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20191511321",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85066117677",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85066117677",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "627991251",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "77782399",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.2217/pgs-2018-0196"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "57",
                "reference": [
                    {
                        "ref-fulltext": "Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (2016). https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "84855616052",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Panel on Antiretroviral Guidelines for Adults and Adolescents",
                            "ref-sourcetitle": "Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents"
                        },
                        "ce:source-text": "Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (2016). https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf"
                    },
                    {
                        "ref-fulltext": "Thailand National Guidelines on HIV/AIDS Treatment and Prevention. Department of Disease Control, Ministry of Public Health (2017). https://aidssti.ddc.moph.go.th/contents/download/1768",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://aidssti.ddc.moph.go.th/contents/download/1768",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85066154189",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Thailand National Guidelines on HIV/AIDS Treatment and Prevention Department of Disease Control, Ministry of Public Health"
                        },
                        "ce:source-text": "Thailand National Guidelines on HIV/AIDS Treatment and Prevention. Department of Disease Control, Ministry of Public Health (2017). https://aidssti.ddc.moph.go.th/contents/download/1768"
                    },
                    {
                        "ref-fulltext": "Croom KF, Dhillon S, Keam SJ. Atazanavir: a review of its use in the management of HIV-1 infection. Drugs 69(8), 1107-1140 (2009).",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Atazanavir: A review of its use in the management of HIV-1 infection"},
                            "refd-itemidlist": {"itemid": {
                                "$": "67049086180",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "69",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "1107",
                                    "@last": "1140"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Croom",
                                    "ce:indexed-name": "Croom K.F."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Dhillon",
                                    "ce:indexed-name": "Dhillon S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Keam",
                                    "ce:indexed-name": "Keam S.J."
                                }
                            ]},
                            "ref-sourcetitle": "Drugs"
                        },
                        "ce:source-text": "Croom KF, Dhillon S, Keam SJ. Atazanavir: a review of its use in the management of HIV-1 infection. Drugs 69(8), 1107-1140 (2009)."
                    },
                    {
                        "ref-fulltext": "Le Tiec C, Barrail A, Goujard C, Taburet A-M. Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir. Clin. Pharm. 44(10), 1035-1050 (2005).",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir"},
                            "refd-itemidlist": {"itemid": {
                                "$": "25144448034",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "44",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1035",
                                    "@last": "1050"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Le Tiec",
                                    "ce:indexed-name": "Le Tiec C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Barrail",
                                    "ce:indexed-name": "Barrail A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Goujard",
                                    "ce:indexed-name": "Goujard C."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A.-M.",
                                    "@_fa": "true",
                                    "ce:surname": "Taburet",
                                    "ce:indexed-name": "Taburet A.-M."
                                }
                            ]},
                            "ref-sourcetitle": "Clin. Pharm."
                        },
                        "ce:source-text": "Le Tiec C, Barrail A, Goujard C, Taburet A-M. Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir. Clin. Pharm. 44(10), 1035-1050 (2005)."
                    },
                    {
                        "ref-fulltext": "Gonzalez De Requena D, Bonora S, Canta F et al. Atazanavir Ctrough is associated with efficacy and safety: definition of therapeutic range. Presented at: 6th International Workshop on Clinical Pharmacology of HIV Therapy. QC, Canada, April 28-30, 2005.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Atazanavir Ctrough is associated with efficacy and safety: Definition of therapeutic range"},
                            "refd-itemidlist": {"itemid": {
                                "$": "27644462369",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "QC, Canada, April 28-30",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Gonzalez De Requena",
                                        "ce:indexed-name": "Gonzalez De Requena D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Bonora",
                                        "ce:indexed-name": "Bonora S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Canta",
                                        "ce:indexed-name": "Canta F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "6th International Workshop on Clinical Pharmacology of HIV Therapy"
                        },
                        "ce:source-text": "Gonzalez De Requena D, Bonora S, Canta F et al. Atazanavir Ctrough is associated with efficacy and safety: definition of therapeutic range. Presented at: 6th International Workshop on Clinical Pharmacology of HIV Therapy. QC, Canada, April 28-30, 2005."
                    },
                    {
                        "ref-fulltext": "Smith D, Jeganathan S, Ray J. Atazanavir plasma concentrations vary significantly between patients and correlate with increased serum bilirubin concentrations. HIV Clin. Trials 7(1), 34-38 (2006).",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Atazanavir plasma concentrations vary significantly between patients and correlate with increased serum bilirubin concentrations"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33646596272",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "34",
                                    "@last": "38"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Smith",
                                    "ce:indexed-name": "Smith D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Jeganathan",
                                    "ce:indexed-name": "Jeganathan S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Ray",
                                    "ce:indexed-name": "Ray J."
                                }
                            ]},
                            "ref-sourcetitle": "HIV Clin. Trials"
                        },
                        "ce:source-text": "Smith D, Jeganathan S, Ray J. Atazanavir plasma concentrations vary significantly between patients and correlate with increased serum bilirubin concentrations. HIV Clin. Trials 7(1), 34-38 (2006)."
                    },
                    {
                        "ref-fulltext": "Cleijsen RM, Van De Ende ME, Kroon FP et al. Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice. J. Antimicrob. Chemother. 60(4), 897-900 (2007).",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34548784342",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "60",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "897",
                                    "@last": "900"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Cleijsen",
                                        "ce:indexed-name": "Cleijsen R.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Van De Ende",
                                        "ce:indexed-name": "Van De Ende M.E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Kroon",
                                        "ce:indexed-name": "Kroon F.P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Antimicrob. Chemother."
                        },
                        "ce:source-text": "Cleijsen RM, Van De Ende ME, Kroon FP et al. Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice. J. Antimicrob. Chemother. 60(4), 897-900 (2007)."
                    },
                    {
                        "ref-fulltext": "Bertz RJ, Persson A, Chung E et al. Pharmacokinetics and pharmacodynamics of atazanavir-containing antiretroviral regimens, with or without ritonavir, in patients who are HIV-positive and treatment-naive. Pharmacotherapy 33(3), 284-294 (2013).",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Pharmacokinetics and pharmacodynamics of atazanavir-containing antiretroviral regimens, with or without ritonavir, in patients who are HIV-positive and treatment-naive"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84875423255",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "33",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "284",
                                    "@last": "294"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Bertz",
                                        "ce:indexed-name": "Bertz R.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Persson",
                                        "ce:indexed-name": "Persson A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Chung",
                                        "ce:indexed-name": "Chung E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmacotherapy"
                        },
                        "ce:source-text": "Bertz RJ, Persson A, Chung E et al. Pharmacokinetics and pharmacodynamics of atazanavir-containing antiretroviral regimens, with or without ritonavir, in patients who are HIV-positive and treatment-naive. Pharmacotherapy 33(3), 284-294 (2013)."
                    },
                    {
                        "ref-fulltext": "Fabbiani M, Di Giambenedetto S, Bracciale L et al. Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice. J. Antimicrob. Chemother. 64(1), 109-117 (2009).",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice"},
                            "refd-itemidlist": {"itemid": {
                                "$": "67249131485",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "64",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "109",
                                    "@last": "117"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Fabbiani",
                                        "ce:indexed-name": "Fabbiani M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Di Giambenedetto",
                                        "ce:indexed-name": "Di Giambenedetto S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Bracciale",
                                        "ce:indexed-name": "Bracciale L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Antimicrob. Chemother."
                        },
                        "ce:source-text": "Fabbiani M, Di Giambenedetto S, Bracciale L et al. Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice. J. Antimicrob. Chemother. 64(1), 109-117 (2009)."
                    },
                    {
                        "ref-fulltext": "Winston A, Jose S, Gibbons S et al. Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring. J. Antimicrob. Chemother. 68(6), 1354-1359 (2013).",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84883244574",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "68",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1354",
                                    "@last": "1359"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Winston",
                                        "ce:indexed-name": "Winston A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Jose",
                                        "ce:indexed-name": "Jose S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Gibbons",
                                        "ce:indexed-name": "Gibbons S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Antimicrob. Chemother."
                        },
                        "ce:source-text": "Winston A, Jose S, Gibbons S et al. Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring. J. Antimicrob. Chemother. 68(6), 1354-1359 (2013)."
                    },
                    {
                        "ref-fulltext": "Punyawudho B, Thammajaruk N, Ruxrungtham K, Avihingsanon A. Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients. Int. J. Antimicrob. Agents 49(3), 327-332 (2017).",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85011066657",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "49",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "327",
                                    "@last": "332"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Punyawudho",
                                    "ce:indexed-name": "Punyawudho B."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Thammajaruk",
                                    "ce:indexed-name": "Thammajaruk N."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Ruxrungtham",
                                    "ce:indexed-name": "Ruxrungtham K."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Avihingsanon",
                                    "ce:indexed-name": "Avihingsanon A."
                                }
                            ]},
                            "ref-sourcetitle": "Int. J. Antimicrob. Agents"
                        },
                        "ce:source-text": "Punyawudho B, Thammajaruk N, Ruxrungtham K, Avihingsanon A. Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients. Int. J. Antimicrob. Agents 49(3), 327-332 (2017)."
                    },
                    {
                        "ref-fulltext": "Amadasi S, Odolini S, Foca E et al. Evaluation of boosted and unboosted atazanavir plasma concentration in HIV infected patients. Curr. HIV Res. 11(8), 642-646 (2013).",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Evaluation of boosted and unboosted atazanavir plasma concentration in HIV infected patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84900469083",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "11",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "642",
                                    "@last": "646"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Amadasi",
                                        "ce:indexed-name": "Amadasi S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Odolini",
                                        "ce:indexed-name": "Odolini S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Foca",
                                        "ce:indexed-name": "Foca E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Curr. HIV Res."
                        },
                        "ce:source-text": "Amadasi S, Odolini S, Foca E et al. Evaluation of boosted and unboosted atazanavir plasma concentration in HIV infected patients. Curr. HIV Res. 11(8), 642-646 (2013)."
                    },
                    {
                        "ref-fulltext": "Venuto CS, Mollan K, Ma Q et al. Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202. J. Antimicrob. Chemother. 69(12), 3300-3310 (2014).",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84960146946",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "69",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "3300",
                                    "@last": "3310"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Venuto",
                                        "ce:indexed-name": "Venuto C.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Mollan",
                                        "ce:indexed-name": "Mollan K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Ma",
                                        "ce:indexed-name": "Ma Q."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Antimicrob. Chemother."
                        },
                        "ce:source-text": "Venuto CS, Mollan K, Ma Q et al. Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202. J. Antimicrob. Chemother. 69(12), 3300-3310 (2014)."
                    },
                    {
                        "ref-fulltext": "Kile DA, Mawhinney S, Aquilante CL, Rower JE, Castillo-Mancilla JR, Anderson PL. A population pharmacokinetic-pharmacogenetic analysis of atazanavir. AIDS Res. Hum. Retroviruses 28(10), 1227-1234 (2012).",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "A population pharmacokinetic-pharmacogenetic analysis of atazanavir"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84866696853",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "28",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1227",
                                    "@last": "1234"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Kile",
                                    "ce:indexed-name": "Kile D.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Mawhinney",
                                    "ce:indexed-name": "Mawhinney S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Aquilante",
                                    "ce:indexed-name": "Aquilante C.L."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Rower",
                                    "ce:indexed-name": "Rower J.E."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Castillo-Mancilla",
                                    "ce:indexed-name": "Castillo-Mancilla J.R."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "P.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Anderson",
                                    "ce:indexed-name": "Anderson P.L."
                                }
                            ]},
                            "ref-sourcetitle": "AIDS Res. Hum. Retroviruses"
                        },
                        "ce:source-text": "Kile DA, Mawhinney S, Aquilante CL, Rower JE, Castillo-Mancilla JR, Anderson PL. A population pharmacokinetic-pharmacogenetic analysis of atazanavir. AIDS Res. Hum. Retroviruses 28(10), 1227-1234 (2012)."
                    },
                    {
                        "ref-fulltext": "Goutelle S, Baudry T, Gagnieu MC et al. Pharmacokinetic-pharmacodynamic modeling of unboosted Atazanavir in a cohort of stable HIV-infected patients. Antimicrob. Agents Chemother. 57(1), 517-523 (2013).",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Pharmacokinetic-pharmacodynamic modeling of unboosted Atazanavir in a cohort of stable HIV-infected patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84872029110",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "57",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "517",
                                    "@last": "523"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Goutelle",
                                        "ce:indexed-name": "Goutelle S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Baudry",
                                        "ce:indexed-name": "Baudry T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Gagnieu",
                                        "ce:indexed-name": "Gagnieu M.C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob. Agents Chemother."
                        },
                        "ce:source-text": "Goutelle S, Baudry T, Gagnieu MC et al. Pharmacokinetic-pharmacodynamic modeling of unboosted Atazanavir in a cohort of stable HIV-infected patients. Antimicrob. Agents Chemother. 57(1), 517-523 (2013)."
                    },
                    {
                        "ref-fulltext": "Stohr W, Back D, Dunn D et al. Factors influencing lopinavir and atazanavir plasma concentration. J. Antimicrob. Chemother. 65(1), 129-137 (2010).",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Factors influencing lopinavir and atazanavir plasma concentration"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77950345853",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "65",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "129",
                                    "@last": "137"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Stohr",
                                        "ce:indexed-name": "Stohr W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Back",
                                        "ce:indexed-name": "Back D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Dunn",
                                        "ce:indexed-name": "Dunn D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Antimicrob. Chemother."
                        },
                        "ce:source-text": "Stohr W, Back D, Dunn D et al. Factors influencing lopinavir and atazanavir plasma concentration. J. Antimicrob. Chemother. 65(1), 129-137 (2010)."
                    },
                    {
                        "ref-fulltext": "Dailly E, Tribut O, Tattevin P et al. Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients. Eur. J. Clin. Pharmacol. 62(7), 523-526 (2006).",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33745713170",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "62",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "523",
                                    "@last": "526"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Dailly",
                                        "ce:indexed-name": "Dailly E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "O.",
                                        "@_fa": "true",
                                        "ce:surname": "Tribut",
                                        "ce:indexed-name": "Tribut O."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Tattevin",
                                        "ce:indexed-name": "Tattevin P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur. J. Clin. Pharmacol."
                        },
                        "ce:source-text": "Dailly E, Tribut O, Tattevin P et al. Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients. Eur. J. Clin. Pharmacol. 62(7), 523-526 (2006)."
                    },
                    {
                        "ref-fulltext": "Taburet AM, Piketty C, Chazallon C et al. Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 48(6), 2091-2096 (2004).",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "2542502584",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "48",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "2091",
                                    "@last": "2096"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Taburet",
                                        "ce:indexed-name": "Taburet A.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Piketty",
                                        "ce:indexed-name": "Piketty C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Chazallon",
                                        "ce:indexed-name": "Chazallon C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob. Agents Chemother."
                        },
                        "ce:source-text": "Taburet AM, Piketty C, Chazallon C et al. Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 48(6), 2091-2096 (2004)."
                    },
                    {
                        "ref-fulltext": "Barco E, Nóvoa S. The pharmacogenetics of HIV treatment: a practical clinical approach. J. Pharmacogenomics Pharmacoproteomics 4, 116 (2013).",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "The pharmacogenetics of HIV treatment: A practical clinical approach"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84982751764",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {"@first": "116"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Barco",
                                    "ce:indexed-name": "Barco E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Nóvoa",
                                    "ce:indexed-name": "Novoa S."
                                }
                            ]},
                            "ref-sourcetitle": "J. Pharmacogenomics Pharmacoproteomics"
                        },
                        "ce:source-text": "Barco E, Nóvoa S. The pharmacogenetics of HIV treatment: a practical clinical approach. J. Pharmacogenomics Pharmacoproteomics 4, 116 (2013)."
                    },
                    {
                        "ref-fulltext": "Calcagno A, Cusato J, D'Avolio A, Bonora S. Genetic polymorphisms affecting the pharmacokinetics of antiretroviral drugs. Clin. Pharmacokinet. 56(4), 355-369 (2017).",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Genetic polymorphisms affecting the pharmacokinetics of antiretroviral drugs"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84988418816",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "56",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "355",
                                    "@last": "369"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Calcagno",
                                    "ce:indexed-name": "Calcagno A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Cusato",
                                    "ce:indexed-name": "Cusato J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "D'Avolio",
                                    "ce:indexed-name": "D'Avolio A."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Bonora",
                                    "ce:indexed-name": "Bonora S."
                                }
                            ]},
                            "ref-sourcetitle": "Clin. Pharmacokinet."
                        },
                        "ce:source-text": "Calcagno A, Cusato J, D'Avolio A, Bonora S. Genetic polymorphisms affecting the pharmacokinetics of antiretroviral drugs. Clin. Pharmacokinet. 56(4), 355-369 (2017)."
                    },
                    {
                        "ref-fulltext": "Bonora S, Rusconi S, Calcagno A et al. Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study). J. Antimicrob. Chemother. 70(11), 3096-3099 (2015).",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: A randomized, controlled, pilot study (the REYAGEN study)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84949033574",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "70",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "3096",
                                    "@last": "3099"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Bonora",
                                        "ce:indexed-name": "Bonora S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Rusconi",
                                        "ce:indexed-name": "Rusconi S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Calcagno",
                                        "ce:indexed-name": "Calcagno A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Antimicrob. Chemother."
                        },
                        "ce:source-text": "Bonora S, Rusconi S, Calcagno A et al. Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study). J. Antimicrob. Chemother. 70(11), 3096-3099 (2015)."
                    },
                    {
                        "ref-fulltext": "Phillips EJ, Mallal SA. Personalizing antiretroviral therapy: is it a reality? Per. Med. 6(4), 393-408 (2009).",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Personalizing antiretroviral therapy: Is it a reality?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "68049110629",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "6",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "393",
                                    "@last": "408"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Phillips",
                                    "ce:indexed-name": "Phillips E.J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Mallal",
                                    "ce:indexed-name": "Mallal S.A."
                                }
                            ]},
                            "ref-sourcetitle": "Per. Med."
                        },
                        "ce:source-text": "Phillips EJ, Mallal SA. Personalizing antiretroviral therapy: is it a reality? Per. Med. 6(4), 393-408 (2009)."
                    },
                    {
                        "ref-fulltext": "Pavlos R, Phillips EJ. Individualization of antiretroviral therapy. Pharmgenomics Pers. Med. 5, 1-17 (2012).",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Individualization of antiretroviral therapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84856809606",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "5"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "17"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Pavlos",
                                    "ce:indexed-name": "Pavlos R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Phillips",
                                    "ce:indexed-name": "Phillips E.J."
                                }
                            ]},
                            "ref-sourcetitle": "Pharmgenomics Pers. Med."
                        },
                        "ce:source-text": "Pavlos R, Phillips EJ. Individualization of antiretroviral therapy. Pharmgenomics Pers. Med. 5, 1-17 (2012)."
                    },
                    {
                        "ref-fulltext": "Avihingsanon A, Van Der Lugt J, Kerr SJ et al. A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults. Clin. Pharmacol. Ther. 85(4), 402-408 (2009).",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults"},
                            "refd-itemidlist": {"itemid": {
                                "$": "62649107112",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "85",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "402",
                                    "@last": "408"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Avihingsanon",
                                        "ce:indexed-name": "Avihingsanon A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Der Lugt",
                                        "ce:indexed-name": "Van Der Lugt J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Kerr",
                                        "ce:indexed-name": "Kerr S.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Pharmacol. Ther."
                        },
                        "ce:source-text": "Avihingsanon A, Van Der Lugt J, Kerr SJ et al. A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults. Clin. Pharmacol. Ther. 85(4), 402-408 (2009)."
                    },
                    {
                        "ref-fulltext": "Chaikan A, Chierakul N, Saguenwong N et al. Frequency of functional drug disposition gene polymorphism in Thai population: relevance to antiretroviral drugs. J. Int. AIDS Soc. 11(1), P237 (2008).",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Frequency of functional drug disposition gene polymorphism in Thai population: Relevance to antiretroviral drugs"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85071412822",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "11",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "P237"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Chaikan",
                                        "ce:indexed-name": "Chaikan A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Chierakul",
                                        "ce:indexed-name": "Chierakul N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Saguenwong",
                                        "ce:indexed-name": "Saguenwong N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Int. AIDS Soc."
                        },
                        "ce:source-text": "Chaikan A, Chierakul N, Saguenwong N et al. Frequency of functional drug disposition gene polymorphism in Thai population: relevance to antiretroviral drugs. J. Int. AIDS Soc. 11(1), P237 (2008)."
                    },
                    {
                        "ref-fulltext": "Avihingsanon A, Tongkobpetch S, Kerr SJ et al. Pharmacogenetic testing can identify patients taking atazanavir at risk for hyperbilirubinemia. J. Acquir. Immune Defic. Syndr. 69(1), e36-e37 (2015).",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Pharmacogenetic testing can identify patients taking atazanavir at risk for hyperbilirubinemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84928422012",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "69",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "e36",
                                    "@last": "e37"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Avihingsanon",
                                        "ce:indexed-name": "Avihingsanon A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Tongkobpetch",
                                        "ce:indexed-name": "Tongkobpetch S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Kerr",
                                        "ce:indexed-name": "Kerr S.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Acquir. Immune Defic. Syndr."
                        },
                        "ce:source-text": "Avihingsanon A, Tongkobpetch S, Kerr SJ et al. Pharmacogenetic testing can identify patients taking atazanavir at risk for hyperbilirubinemia. J. Acquir. Immune Defic. Syndr. 69(1), e36-e37 (2015)."
                    },
                    {
                        "ref-fulltext": "Lamba J, Hebert JM, Schuetz EG, Klein TE, Altman RB. PharmGKB summary: very important pharmacogene information for CYP3A5. Pharmacogenet. Genomics 22(7), 555-558 (2012).",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "PharmGKB summary: Very important pharmacogene information for CYP3A5"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84862756288",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "555",
                                    "@last": "558"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Lamba",
                                    "ce:indexed-name": "Lamba J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Hebert",
                                    "ce:indexed-name": "Hebert J.M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "E.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Schuetz",
                                    "ce:indexed-name": "Schuetz E.G."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "T.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Klein",
                                    "ce:indexed-name": "Klein T.E."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "R.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Altman",
                                    "ce:indexed-name": "Altman R.B."
                                }
                            ]},
                            "ref-sourcetitle": "Pharmacogenet. Genomics"
                        },
                        "ce:source-text": "Lamba J, Hebert JM, Schuetz EG, Klein TE, Altman RB. PharmGKB summary: very important pharmacogene information for CYP3A5. Pharmacogenet. Genomics 22(7), 555-558 (2012)."
                    },
                    {
                        "ref-fulltext": "Lamba JK, Lin YS, Schuetz EG, Thummel KE. Genetic contribution to variable human CYP3A-mediated metabolism. Adv. Drug Deliv. Rev. 64, 256-269 (2012).",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Genetic contribution to variable human CYP3A-mediated metabolism"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84870255195",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "256",
                                    "@last": "269"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Lamba",
                                    "ce:indexed-name": "Lamba J.K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Y.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Lin",
                                    "ce:indexed-name": "Lin Y.S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "E.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Schuetz",
                                    "ce:indexed-name": "Schuetz E.G."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "K.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Thummel",
                                    "ce:indexed-name": "Thummel K.E."
                                }
                            ]},
                            "ref-sourcetitle": "Adv. Drug Deliv. Rev."
                        },
                        "ce:source-text": "Lamba JK, Lin YS, Schuetz EG, Thummel KE. Genetic contribution to variable human CYP3A-mediated metabolism. Adv. Drug Deliv. Rev. 64, 256-269 (2012)."
                    },
                    {
                        "ref-fulltext": "Anderson PL, Aquilante CL, Gardner EM et al. Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors. J. Antimicrob. Chemother. 64(5), 1071-1079 (2009).",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors"},
                            "refd-itemidlist": {"itemid": {
                                "$": "73949129834",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "64",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "1071",
                                    "@last": "1079"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Anderson",
                                        "ce:indexed-name": "Anderson P.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Aquilante",
                                        "ce:indexed-name": "Aquilante C.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Gardner",
                                        "ce:indexed-name": "Gardner E.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Antimicrob. Chemother."
                        },
                        "ce:source-text": "Anderson PL, Aquilante CL, Gardner EM et al. Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors. J. Antimicrob. Chemother. 64(5), 1071-1079 (2009)."
                    },
                    {
                        "ref-fulltext": "Savic RM, Barrail-Tran A, Duval X et al. Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients. Clin. Pharmacol. Ther. 92(5), 575-583 (2012).",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84867883813",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "92",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "575",
                                    "@last": "583"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Savic",
                                        "ce:indexed-name": "Savic R.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Barrail-Tran",
                                        "ce:indexed-name": "Barrail-Tran A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Duval",
                                        "ce:indexed-name": "Duval X."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Pharmacol. Ther."
                        },
                        "ce:source-text": "Savic RM, Barrail-Tran A, Duval X et al. Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients. Clin. Pharmacol. Ther. 92(5), 575-583 (2012)."
                    },
                    {
                        "ref-fulltext": "Wolking S, Schaeffeler E, Lerche H, Schwab M, Nies AT. Impact of genetic polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on drug disposition and potential clinical implications: update of the literature. Clin. Pharmacokinet. 54(7), 709-735 (2015).",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Impact of genetic polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on drug disposition and potential clinical implications: Update of the literature"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84933673958",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "54",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "709",
                                    "@last": "735"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Wolking",
                                    "ce:indexed-name": "Wolking S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Schaeffeler",
                                    "ce:indexed-name": "Schaeffeler E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Lerche",
                                    "ce:indexed-name": "Lerche H."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Schwab",
                                    "ce:indexed-name": "Schwab M."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "A.T.",
                                    "@_fa": "true",
                                    "ce:surname": "Nies",
                                    "ce:indexed-name": "Nies A.T."
                                }
                            ]},
                            "ref-sourcetitle": "Clin. Pharmacokinet."
                        },
                        "ce:source-text": "Wolking S, Schaeffeler E, Lerche H, Schwab M, Nies AT. Impact of genetic polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on drug disposition and potential clinical implications: update of the literature. Clin. Pharmacokinet. 54(7), 709-735 (2015)."
                    },
                    {
                        "ref-fulltext": "Alam C, Whyte-Allman SK, Omeragic A, Bendayan R. Role and modulation of drug transporters in HIV-1 therapy. Adv. Drug Deliv. Rev. 103, 121-143 (2016).",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Role and modulation of drug transporters in HIV-1 therapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84975496953",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "103"},
                                "pagerange": {
                                    "@first": "121",
                                    "@last": "143"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Alam",
                                    "ce:indexed-name": "Alam C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Whyte-Allman",
                                    "ce:indexed-name": "Whyte-Allman S.K."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Omeragic",
                                    "ce:indexed-name": "Omeragic A."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Bendayan",
                                    "ce:indexed-name": "Bendayan R."
                                }
                            ]},
                            "ref-sourcetitle": "Adv. Drug Deliv. Rev."
                        },
                        "ce:source-text": "Alam C, Whyte-Allman SK, Omeragic A, Bendayan R. Role and modulation of drug transporters in HIV-1 therapy. Adv. Drug Deliv. Rev. 103, 121-143 (2016)."
                    },
                    {
                        "ref-fulltext": "Rodriguez Novoa S, Barreiro P, Rendon A et al. Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C->T polymorphism at the multidrug resistance gene 1. Clin. Infect. Dis. 42(2), 291-295 (2006).",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C->T polymorphism at the multidrug resistance gene 1"},
                            "refd-itemidlist": {"itemid": {
                                "$": "30144438738",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "42",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "291",
                                    "@last": "295"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Rodriguez Novoa",
                                        "ce:indexed-name": "Rodriguez Novoa S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Barreiro",
                                        "ce:indexed-name": "Barreiro P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Rendon",
                                        "ce:indexed-name": "Rendon A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Infect. Dis."
                        },
                        "ce:source-text": "Rodriguez Novoa S, Barreiro P, Rendon A et al. Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C->T polymorphism at the multidrug resistance gene 1. Clin. Infect. Dis. 42(2), 291-295 (2006)."
                    },
                    {
                        "ref-fulltext": "Rodriguez-Novoa S, Martin-Carbonero L, Barreiro P et al. Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia. AIDS 21(1), 41-46 (2007).",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33845495422",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "41",
                                    "@last": "46"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Rodriguez-Novoa",
                                        "ce:indexed-name": "Rodriguez-Novoa S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Martin-Carbonero",
                                        "ce:indexed-name": "Martin-Carbonero L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Barreiro",
                                        "ce:indexed-name": "Barreiro P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Rodriguez-Novoa S, Martin-Carbonero L, Barreiro P et al. Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia. AIDS 21(1), 41-46 (2007)."
                    },
                    {
                        "ref-fulltext": "D'avolio A, Carcieri C, Cusato J et al. Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms. J. Antimicrob. Chemother. 69(11), 3061-3066 (2014).",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84923065347",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "69",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "3061",
                                    "@last": "3066"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "D'Avolio",
                                        "ce:indexed-name": "D'Avolio A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Carcieri",
                                        "ce:indexed-name": "Carcieri C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Cusato",
                                        "ce:indexed-name": "Cusato J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Antimicrob. Chemother."
                        },
                        "ce:source-text": "D'avolio A, Carcieri C, Cusato J et al. Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms. J. Antimicrob. Chemother. 69(11), 3061-3066 (2014)."
                    },
                    {
                        "ref-fulltext": "Park WB, Choe PG, Song K-H et al. Genetic factors influencing severe atazanavir-associated hyperbilirubinemia in a population with low UDP-glucuronosyltransferase 1A1∗ 28 allele frequency. Clin. Infect. Dis. 51(1), 101-106 (2010).",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Genetic factors influencing severe atazanavir-associated hyperbilirubinemia in a population with low UDP-glucuronosyltransferase 1A1∗ 28 allele frequency"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77953775606",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "51",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "101",
                                    "@last": "106"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Park",
                                        "ce:indexed-name": "Park W.B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Choe",
                                        "ce:indexed-name": "Choe P.G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.-H.",
                                        "@_fa": "true",
                                        "ce:surname": "Song",
                                        "ce:indexed-name": "Song K.-H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Infect. Dis."
                        },
                        "ce:source-text": "Park WB, Choe PG, Song K-H et al. Genetic factors influencing severe atazanavir-associated hyperbilirubinemia in a population with low UDP-glucuronosyltransferase 1A1∗ 28 allele frequency. Clin. Infect. Dis. 51(1), 101-106 (2010)."
                    },
                    {
                        "ref-fulltext": "Griffin L, Annaert P, Brouwer KL. Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors. J. Pharm. Sci. 100(9), 3636-3654 (2011).",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79960133743",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "100",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "3636",
                                    "@last": "3654"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Griffin",
                                    "ce:indexed-name": "Griffin L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Annaert",
                                    "ce:indexed-name": "Annaert P."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Brouwer",
                                    "ce:indexed-name": "Brouwer K.L."
                                }
                            ]},
                            "ref-sourcetitle": "J. Pharm. Sci."
                        },
                        "ce:source-text": "Griffin L, Annaert P, Brouwer KL. Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors. J. Pharm. Sci. 100(9), 3636-3654 (2011)."
                    },
                    {
                        "ref-fulltext": "Rakhmanina NY, Neely MN, Van Schaik RH et al. CYP3A5, ABCB1, and SLCO1B1 polymorphisms and pharmacokinetics and virologic outcome of lopinavir/ritonavir in HIV-infected children. Ther. Drug Monit. 33(4), 417-424 (2011).",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "CYP3A5, ABCB1, and SLCO1B1 polymorphisms and pharmacokinetics and virologic outcome of lopinavir/ritonavir in HIV-infected children"},
                            "refd-itemidlist": {"itemid": {
                                "$": "80051792323",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "33",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "417",
                                    "@last": "424"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Rakhmanina",
                                        "ce:indexed-name": "Rakhmanina N.Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Neely",
                                        "ce:indexed-name": "Neely M.N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Schaik",
                                        "ce:indexed-name": "Van Schaik R.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ther. Drug Monit."
                        },
                        "ce:source-text": "Rakhmanina NY, Neely MN, Van Schaik RH et al. CYP3A5, ABCB1, and SLCO1B1 polymorphisms and pharmacokinetics and virologic outcome of lopinavir/ritonavir in HIV-infected children. Ther. Drug Monit. 33(4), 417-424 (2011)."
                    },
                    {
                        "ref-fulltext": "Zhang X, Tierney C, Albrecht M et al. Discordant associations between SLCO1B1 521T->C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146. Ther. Drug Monit. 35(2), 209-216 (2013).",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Discordant associations between SLCO1B1 521T->C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84875199086",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "35",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "209",
                                    "@last": "216"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang X."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Tierney",
                                        "ce:indexed-name": "Tierney C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Albrecht",
                                        "ce:indexed-name": "Albrecht M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ther. Drug Monit."
                        },
                        "ce:source-text": "Zhang X, Tierney C, Albrecht M et al. Discordant associations between SLCO1B1 521T->C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146. Ther. Drug Monit. 35(2), 209-216 (2013)."
                    },
                    {
                        "ref-fulltext": "Kohlrausch FB, De Cassia Estrela R, Barroso PF, Suarez-Kurtz G. The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men. Br. J. Clin. Pharmacol. 69(1), 95-98 (2010).",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men"},
                            "refd-itemidlist": {"itemid": {
                                "$": "72949097439",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "69",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "95",
                                    "@last": "98"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "F.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Kohlrausch",
                                    "ce:indexed-name": "Kohlrausch F.B."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "De Cassia Estrela",
                                    "ce:indexed-name": "De Cassia Estrela R."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Barroso",
                                    "ce:indexed-name": "Barroso P.F."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Suarez-Kurtz",
                                    "ce:indexed-name": "Suarez-Kurtz G."
                                }
                            ]},
                            "ref-sourcetitle": "Br. J. Clin. Pharmacol."
                        },
                        "ce:source-text": "Kohlrausch FB, De Cassia Estrela R, Barroso PF, Suarez-Kurtz G. The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men. Br. J. Clin. Pharmacol. 69(1), 95-98 (2010)."
                    },
                    {
                        "ref-fulltext": "Hartkoorn RC, Kwan WS, Shallcross V et al. HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms. Pharmacogenet. Genomics 20(2), 112-120 (2010).",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms"},
                            "refd-itemidlist": {"itemid": {
                                "$": "75649091119",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "20",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "112",
                                    "@last": "120"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Hartkoorn",
                                        "ce:indexed-name": "Hartkoorn R.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kwan",
                                        "ce:indexed-name": "Kwan W.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Shallcross",
                                        "ce:indexed-name": "Shallcross V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmacogenet. Genomics"
                        },
                        "ce:source-text": "Hartkoorn RC, Kwan WS, Shallcross V et al. HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms. Pharmacogenet. Genomics 20(2), 112-120 (2010)."
                    },
                    {
                        "ref-fulltext": "Castillo-Mancilla JR, Aquilante CL, Wempe MF et al. Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342). J. Antimicrob. Chemother. 71(6), 1609-1618 (2016).",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: A sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84973349104",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "71",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1609",
                                    "@last": "1618"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Castillo-Mancilla",
                                        "ce:indexed-name": "Castillo-Mancilla J.R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Aquilante",
                                        "ce:indexed-name": "Aquilante C.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Wempe",
                                        "ce:indexed-name": "Wempe M.F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Antimicrob. Chemother."
                        },
                        "ce:source-text": "Castillo-Mancilla JR, Aquilante CL, Wempe MF et al. Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342). J. Antimicrob. Chemother. 71(6), 1609-1618 (2016)."
                    },
                    {
                        "ref-fulltext": "Ihunnah CA, Jiang M, Xie W. Nuclear receptor PXR, transcriptional circuits and metabolic relevance. Biochim. Biophys. Acta 1812(8), 956-963 (2011).",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Nuclear receptor PXR, transcriptional circuits and metabolic relevance"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79958268830",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "1812",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "956",
                                    "@last": "963"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Ihunnah",
                                    "ce:indexed-name": "Ihunnah C.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Jiang",
                                    "ce:indexed-name": "Jiang M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Xie",
                                    "ce:indexed-name": "Xie W."
                                }
                            ]},
                            "ref-sourcetitle": "Biochim. Biophys. Acta"
                        },
                        "ce:source-text": "Ihunnah CA, Jiang M, Xie W. Nuclear receptor PXR, transcriptional circuits and metabolic relevance. Biochim. Biophys. Acta 1812(8), 956-963 (2011)."
                    },
                    {
                        "ref-fulltext": "Siccardi M, D'Avolio A, Baietto L et al. Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C→T) with reduced concentrations of unboosted atazanavir. Clin. Infect. Dis. 47(9), 1222-1225 (2008).",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C→T) with reduced concentrations of unboosted atazanavir"},
                            "refd-itemidlist": {"itemid": {
                                "$": "53349160769",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "47",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1222",
                                    "@last": "1225"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Siccardi",
                                        "ce:indexed-name": "Siccardi M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "D'Avolio",
                                        "ce:indexed-name": "D'Avolio A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Baietto",
                                        "ce:indexed-name": "Baietto L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Infect. Dis."
                        },
                        "ce:source-text": "Siccardi M, D'Avolio A, Baietto L et al. Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C→T) with reduced concentrations of unboosted atazanavir. Clin. Infect. Dis. 47(9), 1222-1225 (2008)."
                    },
                    {
                        "ref-fulltext": "Schipani A, Siccardi M, D'Avolio A et al. Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance. Antimicrob. Agents Chemother. 54(12), 5242-5250 (2010).",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance"},
                            "refd-itemidlist": {"itemid": {
                                "$": "78649673343",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "54",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "5242",
                                    "@last": "5250"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Schipani",
                                        "ce:indexed-name": "Schipani A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Siccardi",
                                        "ce:indexed-name": "Siccardi M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "D'Avolio",
                                        "ce:indexed-name": "D'Avolio A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob. Agents Chemother."
                        },
                        "ce:source-text": "Schipani A, Siccardi M, D'Avolio A et al. Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance. Antimicrob. Agents Chemother. 54(12), 5242-5250 (2010)."
                    },
                    {
                        "ref-fulltext": "Bunupuradah T, Kiertiburanakul S, Avihingsanon A et al. Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial. Lancet HIV 3(8), e343-350 (2016).",
                        "@id": "46",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): A randomised, open-label, non-inferiority trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84969667316",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "3",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "e343",
                                    "@last": "350"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Bunupuradah",
                                        "ce:indexed-name": "Bunupuradah T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kiertiburanakul",
                                        "ce:indexed-name": "Kiertiburanakul S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Avihingsanon",
                                        "ce:indexed-name": "Avihingsanon A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet HIV"
                        },
                        "ce:source-text": "Bunupuradah T, Kiertiburanakul S, Avihingsanon A et al. Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial. Lancet HIV 3(8), e343-350 (2016)."
                    },
                    {
                        "ref-fulltext": "Burger D, Teulen M, Eerland J, Harteveld A, Aarnoutse R, Touw D. The International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in Plasma: a global proficiency testing program. Ther. Drug Monit. 33(2), 239-243 (2011).",
                        "@id": "47",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "The International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in Plasma: A global proficiency testing program"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79953216672",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "33",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "239",
                                    "@last": "243"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Burger",
                                    "ce:indexed-name": "Burger D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Teulen",
                                    "ce:indexed-name": "Teulen M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Eerland",
                                    "ce:indexed-name": "Eerland J."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Harteveld",
                                    "ce:indexed-name": "Harteveld A."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Aarnoutse",
                                    "ce:indexed-name": "Aarnoutse R."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Touw",
                                    "ce:indexed-name": "Touw D."
                                }
                            ]},
                            "ref-sourcetitle": "Ther. Drug Monit."
                        },
                        "ce:source-text": "Burger D, Teulen M, Eerland J, Harteveld A, Aarnoutse R, Touw D. The International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in Plasma: a global proficiency testing program. Ther. Drug Monit. 33(2), 239-243 (2011)."
                    },
                    {
                        "ref-fulltext": "Solas C, Simon N, Drogoul MP et al. Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients. Br. J. Clin. Pharmacol. 64(3), 353-362 (2007).",
                        "@id": "48",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34548036943",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "64",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "353",
                                    "@last": "362"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Solas",
                                        "ce:indexed-name": "Solas C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Simon",
                                        "ce:indexed-name": "Simon N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Drogoul",
                                        "ce:indexed-name": "Drogoul M.P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br. J. Clin. Pharmacol."
                        },
                        "ce:source-text": "Solas C, Simon N, Drogoul MP et al. Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients. Br. J. Clin. Pharmacol. 64(3), 353-362 (2007)."
                    },
                    {
                        "ref-fulltext": "Bertrand J, Treluyer JM, Panhard X et al. Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAART. Eur. J. Clin. Pharmacol. 65(7), 667-678 (2009).",
                        "@id": "49",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAART"},
                            "refd-itemidlist": {"itemid": {
                                "$": "67649126219",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "65",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "667",
                                    "@last": "678"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Bertrand",
                                        "ce:indexed-name": "Bertrand J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Treluyer",
                                        "ce:indexed-name": "Treluyer J.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Panhard",
                                        "ce:indexed-name": "Panhard X."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur. J. Clin. Pharmacol."
                        },
                        "ce:source-text": "Bertrand J, Treluyer JM, Panhard X et al. Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAART. Eur. J. Clin. Pharmacol. 65(7), 667-678 (2009)."
                    },
                    {
                        "ref-fulltext": "Estrela RC, Santoro AB, Barroso PF, Tuyama M, Suarez-Kurtz G. CYP3A5 genotype has no impact on plasma trough concentrations of lopinavir and ritonavir in HIV-infected subjects. Clin. Pharmacol. Ther. 84(2), 205-207 (2008).",
                        "@id": "50",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "CYP3A5 genotype has no impact on plasma trough concentrations of lopinavir and ritonavir in HIV-infected subjects"},
                            "refd-itemidlist": {"itemid": {
                                "$": "49149099280",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "84",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "205",
                                    "@last": "207"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Estrela",
                                    "ce:indexed-name": "Estrela R.C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Santoro",
                                    "ce:indexed-name": "Santoro A.B."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Barroso",
                                    "ce:indexed-name": "Barroso P.F."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Tuyama",
                                    "ce:indexed-name": "Tuyama M."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Suarez-Kurtz",
                                    "ce:indexed-name": "Suarez-Kurtz G."
                                }
                            ]},
                            "ref-sourcetitle": "Clin. Pharmacol. Ther."
                        },
                        "ce:source-text": "Estrela RC, Santoro AB, Barroso PF, Tuyama M, Suarez-Kurtz G. CYP3A5 genotype has no impact on plasma trough concentrations of lopinavir and ritonavir in HIV-infected subjects. Clin. Pharmacol. Ther. 84(2), 205-207 (2008)."
                    },
                    {
                        "ref-fulltext": "Niemi M, Pasanen MK, Neuvonen PJ. Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol. Rev. 63(1), 157-181 (2011).",
                        "@id": "51",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Organic anion transporting polypeptide 1B1: A genetically polymorphic transporter of major importance for hepatic drug uptake"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79953901458",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "63",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "157",
                                    "@last": "181"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Niemi",
                                    "ce:indexed-name": "Niemi M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Pasanen",
                                    "ce:indexed-name": "Pasanen M.K."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Neuvonen",
                                    "ce:indexed-name": "Neuvonen P.J."
                                }
                            ]},
                            "ref-sourcetitle": "Pharmacol. Rev."
                        },
                        "ce:source-text": "Niemi M, Pasanen MK, Neuvonen PJ. Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol. Rev. 63(1), 157-181 (2011)."
                    },
                    {
                        "ref-fulltext": "Gong IY, Kim RB. Impact of genetic variation in OATP transporters to drug disposition and response. Drug Metab. Pharmacokinet. 28(1), 4-18 (2013).",
                        "@id": "52",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Impact of genetic variation in OATP transporters to drug disposition and response"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84874606257",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "28",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "4",
                                    "@last": "18"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "I.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Gong",
                                    "ce:indexed-name": "Gong I.Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Kim",
                                    "ce:indexed-name": "Kim R.B."
                                }
                            ]},
                            "ref-sourcetitle": "Drug Metab. Pharmacokinet."
                        },
                        "ce:source-text": "Gong IY, Kim RB. Impact of genetic variation in OATP transporters to drug disposition and response. Drug Metab. Pharmacokinet. 28(1), 4-18 (2013)."
                    },
                    {
                        "ref-fulltext": "Schipani A, Egan D, Dickinson L et al. Estimation of the effect of SLCO1B1 polymorphisms on lopinavir plasma concentration in HIV-infected adults. Antivir. Ther. 17(5), 861-868 (2012).",
                        "@id": "53",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Estimation of the effect of SLCO1B1 polymorphisms on lopinavir plasma concentration in HIV-infected adults"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84865709630",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "17",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "861",
                                    "@last": "868"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Schipani",
                                        "ce:indexed-name": "Schipani A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Egan",
                                        "ce:indexed-name": "Egan D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Dickinson",
                                        "ce:indexed-name": "Dickinson L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antivir. Ther."
                        },
                        "ce:source-text": "Schipani A, Egan D, Dickinson L et al. Estimation of the effect of SLCO1B1 polymorphisms on lopinavir plasma concentration in HIV-infected adults. Antivir. Ther. 17(5), 861-868 (2012)."
                    },
                    {
                        "ref-fulltext": "Rekic D, Clewe O, Roshammar D et al. Bilirubin - a potential marker of drug exposure in atazanavir-based antiretroviral therapy. AAPS J. 13(4), 598-605 (2011).",
                        "@id": "54",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Bilirubin - A potential marker of drug exposure in atazanavir-based antiretroviral therapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "83555168318",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "13",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "598",
                                    "@last": "605"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Rekic",
                                        "ce:indexed-name": "Rekic D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "O.",
                                        "@_fa": "true",
                                        "ce:surname": "Clewe",
                                        "ce:indexed-name": "Clewe O."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Roshammar",
                                        "ce:indexed-name": "Roshammar D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AAPS J."
                        },
                        "ce:source-text": "Rekic D, Clewe O, Roshammar D et al. Bilirubin - a potential marker of drug exposure in atazanavir-based antiretroviral therapy. AAPS J. 13(4), 598-605 (2011)."
                    },
                    {
                        "ref-fulltext": "Chiou WJ, De Morais SM, Kikuchi R, Voorman RL, Li X, Bow DA. In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia. Xenobiotica 44(3), 276-282 (2014).",
                        "@id": "55",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84893565092",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "44",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "276",
                                    "@last": "282"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "W.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Chiou",
                                    "ce:indexed-name": "Chiou W.J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.M.",
                                    "@_fa": "true",
                                    "ce:surname": "De Morais",
                                    "ce:indexed-name": "De Morais S.M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Kikuchi",
                                    "ce:indexed-name": "Kikuchi R."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "R.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Voorman",
                                    "ce:indexed-name": "Voorman R.L."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li X."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "D.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Bow",
                                    "ce:indexed-name": "Bow D.A."
                                }
                            ]},
                            "ref-sourcetitle": "Xenobiotica"
                        },
                        "ce:source-text": "Chiou WJ, De Morais SM, Kikuchi R, Voorman RL, Li X, Bow DA. In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia. Xenobiotica 44(3), 276-282 (2014)."
                    },
                    {
                        "ref-fulltext": "Boffito M, Jackson A, Amara A et al. Pharmacokinetics of once-daily darunavir-ritonavir and atazanavir-ritonavir over 72 hours following drug cessation. Antimicrob. Agents Chemother. 55(9), 4218-4223 (2011).",
                        "@id": "56",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Pharmacokinetics of once-daily darunavir-ritonavir and atazanavir-ritonavir over 72 hours following drug cessation"},
                            "refd-itemidlist": {"itemid": {
                                "$": "80051804579",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "55",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "4218",
                                    "@last": "4223"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Boffito",
                                        "ce:indexed-name": "Boffito M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Jackson",
                                        "ce:indexed-name": "Jackson A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Amara",
                                        "ce:indexed-name": "Amara A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob. Agents Chemother."
                        },
                        "ce:source-text": "Boffito M, Jackson A, Amara A et al. Pharmacokinetics of once-daily darunavir-ritonavir and atazanavir-ritonavir over 72 hours following drug cessation. Antimicrob. Agents Chemother. 55(9), 4218-4223 (2011)."
                    },
                    {
                        "ref-fulltext": "Jittikoon J, Mahasirimongkol S, Charoenyingwattana A et al. Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations. J. Hum. Genet. 61(2), 119-127 (2016).",
                        "@id": "57",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84959274497",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "61",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "119",
                                    "@last": "127"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Jittikoon",
                                        "ce:indexed-name": "Jittikoon J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Mahasirimongkol",
                                        "ce:indexed-name": "Mahasirimongkol S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Charoenyingwattana",
                                        "ce:indexed-name": "Charoenyingwattana A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Hum. Genet."
                        },
                        "ce:source-text": "Jittikoon J, Mahasirimongkol S, Charoenyingwattana A et al. Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations. J. Hum. Genet. 61(2), 119-127 (2016)."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "60028333",
            "affilname": "UNSW Sydney",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028333",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60026046",
            "affilname": "Faculty of Medicine, Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026046",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016965",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nijmegen",
            "@id": "60002573",
            "affilname": "Radboud University Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002573",
            "affiliation-country": "Netherlands"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85066117677",
        "dc:description": "Aim: To evaluate the influence of genetic polymorphisms on plasma trough concentrations of atazanavir (ATV) and ritonavir (RTV). Patients & methods: The concentration-to-dose ratios were compared between different genotype groups of CYP3A5, ABCB1, SLCO1B1 and NR1I2 in 490 patients. Multiple regression analysis was used to examine the association between genetic and clinical factors and log-transformed concentration-to-dose ratio of ATV and RTV. Results: Higher concentrations of ATV and RTV were significantly associated with CYP3A5 6986 GG and SLCO1B1 521 TC or CC. Female patients had significantly higher ATV plasma concentration than male patients. Conclusion: Genetic polymorphisms and gender are factors affecting the variability of ATV and RTV concentrations in the Thai population. Thus, genetic testing is worth considering when atazanavir + low dose ritonavir is prescribed.",
        "pubmed-id": "31124411",
        "prism:coverDate": "2019-05-24",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85066117677",
        "dc:creator": {"author": [{
            "ce:given-name": "Noppaket",
            "preferred-name": {
                "ce:given-name": "Noppaket",
                "ce:initials": "N.",
                "ce:surname": "Singkham",
                "ce:indexed-name": "Singkham N."
            },
            "@seq": "1",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60000881",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
                },
                {
                    "@id": "60000881",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
                }
            ],
            "ce:surname": "Singkham",
            "@auid": "55524284500",
            "author-url": "https://api.elsevier.com/content/author/author_id/55524284500",
            "ce:indexed-name": "Singkham N."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85066117677"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85066117677&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85066117677&origin=inward"
            }
        ],
        "source-id": "21167",
        "citedby-count": "3",
        "prism:volume": "20",
        "subtype": "ar",
        "dc:title": "Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients",
        "openaccess": "0",
        "prism:issn": "17448042 14622416",
        "publishercopyright": "© 2019 Future Medicine Ltd.",
        "prism:issueIdentifier": "7",
        "subtypeDescription": "Article",
        "prism:publicationName": "Pharmacogenomics",
        "prism:pageRange": "517-527",
        "prism:endingPage": "527",
        "openaccessFlag": "false",
        "prism:doi": "10.2217/pgs-2018-0196",
        "prism:startingPage": "517",
        "dc:identifier": "SCOPUS_ID:85066117677",
        "dc:publisher": "Future Medicine Ltd.info@futuremedicine.com"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adult",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Anti-HIV Agents",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Atazanavir Sulfate",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Cytochrome P-450 CYP3A",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Genotype",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "HIV Infections",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "HIV Protease Inhibitors",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "HIV-1",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Liver-Specific Organic Anion Transporter 1",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Middle Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Polymorphism, Genetic",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Ritonavir",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Thailand",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "atazanavir"
        },
        {
            "@_fa": "true",
            "$": "CYP3A5 6986A>G"
        },
        {
            "@_fa": "true",
            "$": "plasma concentrations"
        },
        {
            "@_fa": "true",
            "$": "polymorphisms"
        },
        {
            "@_fa": "true",
            "$": "ritonavir"
        },
        {
            "@_fa": "true",
            "$": "SLCO1B1 521T>C"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Genetics",
            "@code": "1311",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Noppaket",
            "preferred-name": {
                "ce:given-name": "Noppaket",
                "ce:initials": "N.",
                "ce:surname": "Singkham",
                "ce:indexed-name": "Singkham N."
            },
            "@seq": "1",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60000881",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
                },
                {
                    "@id": "60000881",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
                }
            ],
            "ce:surname": "Singkham",
            "@auid": "55524284500",
            "author-url": "https://api.elsevier.com/content/author/author_id/55524284500",
            "ce:indexed-name": "Singkham N."
        },
        {
            "ce:given-name": "Anchalee",
            "preferred-name": {
                "ce:given-name": "Anchalee",
                "ce:initials": "A.",
                "ce:surname": "Avihingsanon",
                "ce:indexed-name": "Avihingsanon A."
            },
            "@seq": "2",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60016965",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Avihingsanon",
            "@auid": "57196347321",
            "author-url": "https://api.elsevier.com/content/author/author_id/57196347321",
            "ce:indexed-name": "Avihingsanon A."
        },
        {
            "ce:given-name": "Narukjaporn",
            "preferred-name": {
                "ce:given-name": "Narukjaporn",
                "ce:initials": "N.",
                "ce:surname": "Thammajaruk",
                "ce:indexed-name": "Thammajaruk N."
            },
            "@seq": "3",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60016965",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965"
            },
            "ce:surname": "Thammajaruk",
            "@auid": "36451572800",
            "author-url": "https://api.elsevier.com/content/author/author_id/36451572800",
            "ce:indexed-name": "Thammajaruk N."
        },
        {
            "ce:given-name": "Kiat",
            "preferred-name": {
                "ce:given-name": "Kiat",
                "ce:initials": "K.",
                "ce:surname": "Ruxrungtham",
                "ce:indexed-name": "Ruxrungtham K."
            },
            "@seq": "4",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60016965",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Ruxrungtham",
            "@auid": "7004208798",
            "author-url": "https://api.elsevier.com/content/author/author_id/7004208798",
            "ce:indexed-name": "Ruxrungtham K."
        },
        {
            "ce:given-name": "Torsak",
            "preferred-name": {
                "ce:given-name": "Torsak",
                "ce:initials": "T.",
                "ce:surname": "Bunupuradah",
                "ce:indexed-name": "Bunupuradah T."
            },
            "@seq": "5",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60016965",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965"
            },
            "ce:surname": "Bunupuradah",
            "@auid": "15836773400",
            "author-url": "https://api.elsevier.com/content/author/author_id/15836773400",
            "ce:indexed-name": "Bunupuradah T."
        },
        {
            "ce:given-name": "Sasisopin",
            "preferred-name": {
                "ce:given-name": "Sasisopin",
                "ce:initials": "S.",
                "ce:surname": "Kiertiburanakul",
                "ce:indexed-name": "Kiertiburanakul S."
            },
            "@seq": "6",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199578",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578"
            },
            "ce:surname": "Kiertiburanakul",
            "@auid": "6506539792",
            "author-url": "https://api.elsevier.com/content/author/author_id/6506539792",
            "ce:indexed-name": "Kiertiburanakul S."
        },
        {
            "ce:given-name": "Ploenchan",
            "preferred-name": {
                "ce:given-name": "Ploenchan",
                "ce:initials": "P.",
                "ce:surname": "Chetchotisakd",
                "ce:indexed-name": "Chetchotisakd P."
            },
            "@seq": "7",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60026046",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026046"
            },
            "ce:surname": "Chetchotisakd",
            "@auid": "56992885200",
            "author-url": "https://api.elsevier.com/content/author/author_id/56992885200",
            "ce:indexed-name": "Chetchotisakd P."
        },
        {
            "ce:given-name": "David M.",
            "preferred-name": {
                "ce:given-name": "David M.",
                "ce:initials": "D.M.",
                "ce:surname": "Burger",
                "ce:indexed-name": "Burger D.M."
            },
            "@seq": "8",
            "ce:initials": "D.M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002573",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002573"
            },
            "ce:surname": "Burger",
            "@auid": "55540576000",
            "author-url": "https://api.elsevier.com/content/author/author_id/55540576000",
            "ce:indexed-name": "Burger D.M."
        },
        {
            "ce:given-name": "Sean",
            "preferred-name": {
                "ce:given-name": "Sean",
                "ce:initials": "S.",
                "ce:surname": "Emery",
                "ce:indexed-name": "Emery S."
            },
            "@seq": "9",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028333",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028333"
            },
            "ce:surname": "Emery",
            "@auid": "57188785246",
            "author-url": "https://api.elsevier.com/content/author/author_id/57188785246",
            "ce:indexed-name": "Emery S."
        },
        {
            "ce:given-name": "Baralee",
            "preferred-name": {
                "ce:given-name": "Baralee",
                "ce:initials": "B.",
                "ce:surname": "Punyawudho",
                "ce:indexed-name": "Punyawudho B."
            },
            "@seq": "10",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60000881",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
                },
                {
                    "@id": "60000881",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
                }
            ],
            "ce:surname": "Punyawudho",
            "@auid": "23976628300",
            "author-url": "https://api.elsevier.com/content/author/author_id/23976628300",
            "ce:indexed-name": "Punyawudho B."
        }
    ]}
}}